tradmap

GMED Globus Medical Inc

$78.13 -3.14%

Updated

Healthcare · Surgical & Medical Instruments & Apparatus

Globus Medical Inc (GMED) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $10.5 billion. Shares last traded at $78.13, 22.7% below their 52-week high. Over the past year the stock is up 32.9%. GMED trades at a price-to-earnings ratio of 19.59, below the Surgical & Medical Instruments & Apparatus median of 28.18. Net profit margin is 17.0%, above the peer median of -9.3%. Revenue grew 16.7% year over year.

Market Cap
$10.5B
Shares Out
134.3M
EPS (TTM)
$7.81
P/E Ratio
10.00
P/S Ratio
3.34
P/B Ratio
2.20
Dividend / Share
Dividend Yield
52-Week High
$101.09
52-Week Low
$54.18
Volume
78,755
Avg Vol (3m)
97,958.667

Performance

1W
-5.34%
1M
-2.94%
3M
-2.40%
6M
-12.50%
YTD
-10.48%
1Y
+32.92%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
37.60
SMA (50)
$81.15
SMA (200)
$85.97
Price vs SMA50
-3.72%
Price vs SMA200
-9.12%
ATR (14)
$2.79

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$3.1B
Net Income
$535M
Gross Margin
68.5%
Operating Margin
20.3%
Net Margin
17.0%
Return on Equity
11.2%
Return on Assets
9.8%
Current Ratio
4.62
Debt / Equity
0.15
Revenue Growth (YoY)
+16.7%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $2.00 2026-08-06
Q1 2026 $0.90 2026-05-07
FY 2025 $3.92 2026-02-24
Q3 2025 $2.90 2025-11-06
Q2 2026 $2.01 2026-08-06
Q1 2026 $0.54 2026-05-07

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

GMED vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Updated

P/E vs peers
19.59 / 28.18 med
-30% discount
P/S vs peers
3.34 / 2.94 med
+14% premium
Net margin vs peers
17.0% / -9.3% med
above median
1–14 of 14
SYKStryker Corporation$118.2B31.694.5714.4%-1.31%
MMM3M$86.8B28.973.4511.9%-0.28%
BSXBoston Scientific$68.0B18.543.2417.5%-3.17%
BDXBecton Dickinson$51.1B54.302.454.5%+0.00%
DXCMDexCom$33.9B33.866.8120.1%+0.02%
RMDResMed$33.1B21.705.8526.9%-0.78%
MDLNMedline Inc.$30.7B1.08+0.88%
WSTWest Pharmaceutical Services$24.1B42.677.2517.0%+0.00%
SOLVSolventum$15.7B10.971.8917.3%+0.56%
BAXBaxter International$13.2B-12.441.15-9.3%-0.51%
PENPenumbra Inc$12.7B78.819.0211.4%-0.46%
GKOSGlaukos Corp$10.6B-56.5917.36-30.7%+0.52%
GMEDGlobus Medical Inc$10.5B19.593.3417.0%-3.14%
PODDInsulet Corporation$10.4B27.823.4212.3%+1.63%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.